Brian Wolpin

40PUBLICATIONS
528CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer diagnosisGene mapping
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Nov 03, 2026
A Phase 1 Trial of Low-dose Gemcitabine Combined with ATR Inhibitor Elimusertib for Advanced Solid Tumors.

|Oct 25, 2026
Quantitative gene-level inference of tumor transcription from plasma epigenomes.

|Aug 11, 2026
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

|Jul 08, 2026
Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stage I-III colon cancer.

|May 25, 2026
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.

|Mar 23, 2026
Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery Study.

Ann L Oberg, William R Bamlet, Grant Izmirlian

Pageof 7

Frequent Collaborators

26 joint publications

Andrew J Aguirre

15 joint publications

Kimberly Perez

14 joint publications

Kimmie Ng

14 joint publications

Jonathan O Nowak